Sort
25,944 grants matching “neurodegeneration”
Proteomic Strategies for AIDS and Drug Abuse - HIV and METH CNS Synergy
$945,515Howard S. Fox · University Of Nebraska Medical Center · P01 · FY2010 · DA
A new model of accelerated immune aging in HIV-infected drug users
$945,450Melanie Maria Ott · J. David Gladstone Institutes · DP1 · FY2016 · DA
Training in the Molecular Biology of Neurodegeneration and Alzheimer's Disease
$945,105Bruce A Yankner · Harvard Medical School · T32 · FY2024 · AG
Reimagining Precision Medicine Approaches to AD Diagnosis
$944,809Gil Dan Rabinovici · University Of California, San Francisco · R35 · FY2025 · AG
Design And Development Of Experimental Therapeutics
$943,412Nigel H. Greig · National Institute On Aging · Z01 · FY2008 · AG
Multidimensional investigation of auditory dysfunction in Down syndrome
$942,771Joaquin M. Espinosa · University Of Colorado Denver · R01 · FY2024 · DC
"A Novel Role for the UPR Component, ATF6 in AD-associated Neuroprotective Pathways"
$941,795Randal J. Kaufman · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2019 · AG
The role of the Cockayne syndrome protein
$941,095Vilhelm A Bohr · National Institute On Aging · ZIA · FY2018 · AG
Roles of protein misfolding in neurodegenerative diseases
$940,908Yihong Ye · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2025 · DK
A new model of accelerated immune aging in HIV-infected drug users
$940,675Melanie Maria Ott · J. David Gladstone Institutes · DP1 · FY2015 · DA
Characterizing the Behavior Profile of Healthy Cognitive Aging
$940,498Patricia A Boyle · Rush University Medical Center · R01 · FY2023 · AG
Characterizing the Behavior Profile of Healthy Cognitive Aging
$940,498Patricia A Boyle · Rush University Medical Center · R01 · FY2024 · AG
Characterizing the Behavior Profile of Healthy Cognitive Aging
$940,498Patricia A Boyle · Rush University Medical Center · R01 · FY2022 · AG
Training in the Molecular Biology of Neurodegeneration and Alzheimer's Disease
$939,920Bruce A Yankner · Harvard Medical School · T32 · FY2022 · AG
Innovating Yeast and Human Genetics Approaches to Define Mechanisms of Neurodegenerative Disease
$939,520Aaron D. Gitler · Stanford University · R35 · FY2017 · NS
Enzymes of O-GlcNAc cycling linked to type-2 diabetes and neurodegeneration
$939,098John A. Hanover · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2013 · DK
Targeted disruption the enzymes of O-GlcNAc cycling: Animal models of Disease
$939,098John A. Hanover · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2013 · DK
Multifunctional phase sensors for probing and manipulation of intracellular biomolecular condensates
$939,000Felipe Garcia Quiroz · Emory University · DP2 · FY2025 · GM
Advanced Mass Spectrometry Facility
$938,947David Anderson · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIC · FY2009 · DK
Systems biology of HIV, methamphetamine and antiretrovirals interactions
$937,707Pietro P Sanna · Scripps Research Institute, The · R01 · FY2016 · DA
Spreading Tau Pathology in Non-Amnestic Alzheimer's Disease
$936,751Jeffrey S Phillips · University Of Pennsylvania · R01 · FY2024 · AG
Admin Core - Phase 2
$936,482Vojo P Deretic · University Of New Mexico Health Scis Ctr · P20 · FY2023 · GM
The dynamic architecture of living cells: Uncovering intra-organelle events at nanoscale levels
$935,251Yvette Wong · Northwestern University At Chicago · DP2 · FY2024 · GM
Reducing African Americans' Alzheimer's Disease Risk Through Exercise-MCI Cohort (RAATE-MCI)
$935,236Robert Lee Newton · Lsu Pennington Biomedical Research Ctr · R01 · FY2024 · AG
Targeted disruption the enzymes of O-GlcNAc cycling: Animal models of Disease
$934,873John A. Hanover · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2017 · DK